What You Should Know About Abilify? What Are the Side Effects?

2010-02-22T13:30:43Z

Abilify is an antipsychotic drug used for the treatment of schizophrenia in adults and adolescents 13 to 17 years old. It's as well used to treat manic and mixed episodes associated with bipolar disorder in adults and children and adolescents 10 to 17 years old. Abilify might also be used with antidepressants to treat major depressive disorder in adults.<br><br>What is the most important info I should know about Abilify...

What is Tourettes and Other Tic Disorders and What Are the Facts?

2010-02-22T17:17:19Z

Tics are repetitive, unexpected, nonrhythmic, involuntary movements (motor tics) stereotyped and utterances (phonic tics) that affect separate muscle groups. Tics are often bigger with excitement or anxiousness and best during calm, focused actions. Tics are categorized as either easy or difficult. Easy motor tics are unexpected, brief, repetitive movements that involve a specified list of muscle groups. Transient tic disorder consists of multiple motor tics, phonic tics or both, with duratio...

Bipolar diagnosis jumps in young children: study

2010-02-22T20:04:40Z

<div><p>BOSTON (Reuters) - The number of children aged 2 to 5 who have been diagnosed with bipolar disorder and prescribed powerful antipsychotic drugs has doubled over the past decade, according to research released on Friday.</p><p>The research suggests that while it is still rare to prescribe powerful psychiatric drugs to 2-year-olds, the practice is becoming more frequent...

Drugs can help symptoms of borderline personality

2010-02-22T21:32:36Z

<div><p>NEW YORK (Reuters Health) - While there are no drugs that specifically treat borderline personality disorder, some medications can improve certain symptoms of the psychiatric condition, a new research review finds.</p><p>Borderline personality disorder, or BPD, is a serious mental illness marked by intense mood swings and difficulty with emotional control, impulsive b...

Pfizer's Geodon gets expanded FDA approval

2010-02-24T02:41:08Z

<div id="subtitle">Pfizer's bipolar disorder drug Geodon receives expanded FDA approval</div><div><p>Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.&...

AG says Utah agrees to $24M Zyprexa settlement

2010-02-24T06:49:21Z

<div id="subtitle">Utah agrees to $24M settlement over Eli Lilly's marketing of the Zyprexa anti-psychotic drug</div><div><p>Utah has agreed to a $24 million settlement with Eli Lilly &amp; Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa,

Schering-Plough gets FDA approval for Saphris

2010-02-25T20:23:03Z

<div id="subtitle">Schering-Plough gets FDA approval for schizophrenia, bipolar disorder drug Saphris</div><div><p>Schering-Plough Corp.'s new drug for schizophrenia and bipolar disorder, Saphris, has been approved by the Food and Drug Administration.</p>&...

FDA panel cautiously OKs antipsychotic drugs for kids

2010-02-26T22:39:37Z

<div><p>ADELPHI, Maryland (Reuters) - Three widely used antipsychotic medications appear safe and effective overall in treating children and teenagers with schizophrenia or bipolar disorder, a U.S. advisory panel said on Wednesday.</p><p>The Food and Drug Administration said Wednesday that three blockbuster psychiatric drugs appear safe and effective for children and adolescents, despite side effects that can increase the risk of diabetes.</p><p>The FDA's panel of psychiatric experts voted to approve the use of drugs from Food and Drug Administration are scheduled to vote Wednesday on whether three powerful psychiatric drugs should be approved for children, despite side effects that can increase the risk of diabetes.</p>&am...

FDA panel weighs antipsychotic drug use in kids

2010-02-26T23:50:05Z

<div><p>ADELPHI, Maryland (Reuters) - U.S. advisers began considering on Tuesday whether the makers of three blockbuster antipsychotic drugs should be allowed to promote them for children and teens with schizophrenia or bipolar disorder.</p><p>Reuters) - Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers aim to promote the medicines for youth, U.S. drug reviewers said in documents released on Friday.</p><p>The Reuters) - Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers seek to promote them for younger patients, the head of the U.S. Food and Drug Administration's psychiatric division said in a memo released on Friday.</p><p&...

AstraZeneca e-mails show debate on Seroquel risks

2010-02-27T08:00:21Z

<div id="subtitle">AstraZeneca internal documents show debate between scientists, marketers on Seroquel risks</div><div><p>Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that woul...

Seroquel user wants judge to unseal papers for FDA

2010-03-03T17:27:33Z

<div id="subtitle">Seroquel user wants judge to unseal confidential papers before FDA rules on more uses for drug</div><div><p>A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal maker AstraZeneca's confidential documents about its side effects before Seroquel documents show maker AstraZeneca knew of links to diabetes, weight gain</div><div><p>Internal AstraZeneca reports and e-mails written by company officials show they knew a decade ago that their psychiatric drug Seroquel caused diabetes and major weight gain, plaintiffs' lawyers said Frid...

Crush course set for lithium: ThomWatch

2010-03-02T08:49:29Z

<div id="subtitle">That’s right – crush; rare element sparks scrum</div><div><p>Time for a Wiki speed course in lithium, pegmatite, beryllium and other minerals and chemical elements most of us last reviewed in Geology 201. </p><p>Demand for the rare goodies embedded in pegmatite deposits is starting to look robust. This development comes amid legislators’ support for lithium-powered batteries and other rechargea...

Eli Lilly to pay 1.42 bln dlrs to settle Zyprexa probe

2010-03-02T20:48:26Z

<div><p>US drugmaker Eli Lilly pleaded guilty to violating US law in its marketing of anti-psychotic drug Zyprexa and will pay 1.42 billion dollars to settle criminal and civil allegations, officials said Thursday.</p><p>Eli Lilly said it had entered a misdemeanor plea for violation of federal law in its off-label promotio...

New Study to Evaluate Ways to Control Metabolic Side Effects of Antipsychotics

2010-03-05T12:20:16Z

A new NIMH-funded grant will examine ways to control the metabolic side effects associated with the use of the newer atypical antipsychotic medications in children with schizophrenia or bipolar disorder.

The use of atypical antipsychotic medications to treat children and adolescents with schizophrenia or bipolar disorder is relatively common, but the side effects associated with them are troubling. The recent NIMH-funded Treatment of Early Onset Schizophrenia Study (TEOSS) found that ...

The latest in Bipolar Disorder Medication